These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38905209)

  • 21. The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients.
    Escribano-Lopez I; Diaz-Morales N; Rovira-Llopis S; de Marañon AM; Orden S; Alvarez A; Bañuls C; Rocha M; Murphy MP; Hernandez-Mijares A; Victor VM
    Redox Biol; 2016 Dec; 10():200-205. PubMed ID: 27810734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Muscle Strength Is Associated With Insulin Resistance in Type 2 Diabetes Patients With Osteoarthritis.
    Zaharia OP; Pesta DH; Bobrov P; Kupriyanova Y; Herder C; Karusheva Y; Bódis K; Bönhof GJ; Knitza J; Simon D; Kleyer A; Hwang JH; Müssig K; Ziegler D; Burkart V; Schett G; Roden M; Szendroedi J
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1062-1073. PubMed ID: 33382877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR derived changes of lipoprotein particle concentrations related to impaired fasting glucose, impaired glucose tolerance, or manifest type 2 diabetes mellitus.
    Kalbitzer T; Lobenhofer K; Martin S; Beck Erlach M; Kremer W; Kalbitzer HR
    Lipids Health Dis; 2023 Mar; 22(1):42. PubMed ID: 36964528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study.
    Sulaj A; Kopf S; von Rauchhaupt E; Kliemank E; Brune M; Kender Z; Bartl H; Cortizo FG; Klepac K; Han Z; Kumar V; Longo V; Teleman A; Okun JG; Morgenstern J; Fleming T; Szendroedi J; Herzig S; Nawroth PP
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2167-2181. PubMed ID: 35661214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure to p,p'-dichlorodiphenyldichloroethylene (DDE) induces fasting hyperglycemia without insulin resistance in male C57BL/6H mice.
    Howell GE; Meek E; Kilic J; Mohns M; Mulligan C; Chambers JE
    Toxicology; 2014 Jun; 320():6-14. PubMed ID: 24582731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model.
    Sharavana G; Joseph GS; Baskaran V
    Eur J Nutr; 2017 Dec; 56(8):2475-2485. PubMed ID: 27488609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postprandial metabolite profiles associated with type 2 diabetes clearly stratify individuals with impaired fasting glucose.
    Li-Gao R; de Mutsert R; Rensen PCN; van Klinken JB; Prehn C; Adamski J; van Hylckama Vlieg A; den Heijer M; le Cessie S; Rosendaal FR; Willems van Dijk K; Mook-Kanamori DO
    Metabolomics; 2018; 14(1):13. PubMed ID: 29249917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arbutin ameliorates hyperglycemia, dyslipidemia and oxidative stress and modulates adipocytokines and PPARγ in high-fat diet/streptozotocin-induced diabetic rats.
    Abduh MS; Alzoghaibi MA; Alzoghaibi AM; Bin-Ammar A; Alotaibi MF; Kamel EM; Mahmoud AM
    Life Sci; 2023 May; 321():121612. PubMed ID: 36948387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of alcohol drinking with incident type 2 diabetes and pre-diabetes: The Guangzhou Biobank Cohort Study.
    Li MJ; Ren J; Zhang WS; Jiang CQ; Jin YL; Lam TH; Cheng KK; Thomas GN; Xu L
    Diabetes Metab Res Rev; 2022 Sep; 38(6):e3548. PubMed ID: 35585795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood glucose control for individuals with type-2 diabetes: acute effects of resistance exercise of lower cardiovascular-metabolic stress.
    Moreira SR; Simões GC; Moraes JF; Motta DF; Campbell CS; Simões HG
    J Strength Cond Res; 2012 Oct; 26(10):2806-11. PubMed ID: 22130391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic dysfunction in diabetic offspring: deviations in metabolic flexibility.
    Russell RD; Kraemer RR; Nelson AG
    Med Sci Sports Exerc; 2013 Jan; 45(1):8-15. PubMed ID: 22811035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion.
    Solis-Herrera C; Daniele G; Alatrach M; Agyin C; Triplitt C; Adams J; Patel R; Gastaldelli A; Honka H; Chen X; Abdul-Ghani M; Cersosimo E; Del Prato S; DeFronzo R
    Diabetes Care; 2020 May; 43(5):1065-1069. PubMed ID: 32144165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate metabolism. Evaluation in women with de novo hypertension in late pregnancy.
    Bartha JL; Comino-Delgado R
    J Reprod Med; 1997 Aug; 42(8):489-96. PubMed ID: 9284010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Effects of Chaya against Mitochondrial and Synaptic Toxicities in the Type 2 Diabetes Mouse Model TallyHO.
    Ramasubramanian B; Griffith C; Hanson M; Bunquin LE; Reddy AP; Hegde V; Reddy PH
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of mitochondrial DNA damage at skeletal muscle oxidative stress on the development of type 2 diabetes.
    Dos Santos JM; de Oliveira DS; Moreli ML; Benite-Ribeiro SA
    Mol Cell Biochem; 2018 Dec; 449(1-2):251-255. PubMed ID: 29679277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced reduction in oxidative stress and altered glutathione and thioredoxin system response to unsaturated fatty acid load in familial hypercholesterolemia.
    Cortes R; Martinez-Hervas S; Ivorra C; De Marco G; Gonzalez-Albert V; Rojo-Martínez G; Saez G; Carmena R; Ascaso JF; Real JT; Chaves FJ
    Clin Biochem; 2014 Dec; 47(18):291-7. PubMed ID: 25218830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Type 2 diabetes on Glucokinase diabetes (GCK-MODY) phenotype in a Roma (Gypsy) family - case report.
    Stanik J; Kusekova M; Huckova M; Valentinova L; Masindova I; Stanikova D; Ferenczova J; Gasperikova D; Klimes I
    Endocr Regul; 2012 Apr; 46(2):99-105. PubMed ID: 22540858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis-Driver of Insulin Resistance and Development of Vascular Complications of Diabetes.
    Rabbani N; Xue M; Thornalley PJ
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
    Festa A; D'Agostino R; Hanley AJ; Karter AJ; Saad MF; Haffner SM
    Diabetes; 2004 Jun; 53(6):1549-55. PubMed ID: 15161760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of occult diabetic status and oral glucose intake on brachial artery vasoactivity in patients with peripheral vascular disease.
    Avena R; Curry KM; Sidawy AN; Simpkins JF; Neville RF; Mitchell ME; Bukowski M
    Cardiovasc Surg; 1998 Dec; 6(6):584-9. PubMed ID: 10395260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.